1 Study Coverage 1.1 Hospital Acquired Pneumonia Drugs Product Introduction 1.2 Market Segments 1.3 Key Hospital Acquired Pneumonia Drugs Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Hospital Acquired Pneumonia Drugs Market Size Growth Rate by Type 1.4.2 Phase II 1.4.3 Early Phase (Phase I & II) 1.5 Market by Application 1.5.1 Global Hospital Acquired Pneumonia Drugs Market Size Growth Rate by Application 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Drug Store 1.5.5 E-Commerce 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Hospital Acquired Pneumonia Drugs Market Size, Estimates and Forecasts 2.1.1 Global Hospital Acquired Pneumonia Drugs Revenue 2015-2026 2.1.2 Global Hospital Acquired Pneumonia Drugs Sales 2015-2026 2.2 Global Hospital Acquired Pneumonia Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.3 Hospital Acquired Pneumonia Drugs Historical Market Size by Region (2015-2020) 2.3.1 Global Hospital Acquired Pneumonia Drugs Retrospective Market Scenario in Sales by Region: 2015-2020 2.3.2 Global Hospital Acquired Pneumonia Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020 2.4 Hospital Acquired Pneumonia Drugs Market Estimates and Projections by Region (2021-2026) 2.4.1 Global Hospital Acquired Pneumonia Drugs Sales Forecast by Region (2021-2026) 2.4.2 Global Hospital Acquired Pneumonia Drugs Revenue Forecast by Region (2021-2026) 3 Global Hospital Acquired Pneumonia Drugs Competitor Landscape by Players 3.1 Global Top Hospital Acquired Pneumonia Drugs Sales by Manufacturers 3.1.1 Global Hospital Acquired Pneumonia Drugs Sales by Manufacturers (2015-2020) 3.1.2 Global Hospital Acquired Pneumonia Drugs Sales Market Share by Manufacturers (2015-2020) 3.2 Global Hospital Acquired Pneumonia Drugs Manufacturers by Revenue 3.2.1 Global Hospital Acquired Pneumonia Drugs Revenue by Manufacturers (2015-2020) 3.2.2 Global Hospital Acquired Pneumonia Drugs Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Hospital Acquired Pneumonia Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Hospital Acquired Pneumonia Drugs Revenue in 2019 3.2.5 Global Hospital Acquired Pneumonia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Hospital Acquired Pneumonia Drugs Price by Manufacturers 3.4 Global Hospital Acquired Pneumonia Drugs Manufacturing Base Distribution, Product Types 3.4.1 Hospital Acquired Pneumonia Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Hospital Acquired Pneumonia Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Hospital Acquired Pneumonia Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Hospital Acquired Pneumonia Drugs Market Size by Type (2015-2020) 4.1.1 Global Hospital Acquired Pneumonia Drugs Sales by Type (2015-2020) 4.1.2 Global Hospital Acquired Pneumonia Drugs Revenue by Type (2015-2020) 4.1.3 Hospital Acquired Pneumonia Drugs Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Hospital Acquired Pneumonia Drugs Market Size Forecast by Type (2021-2026) 4.2.1 Global Hospital Acquired Pneumonia Drugs Sales Forecast by Type (2021-2026) 4.2.2 Global Hospital Acquired Pneumonia Drugs Revenue Forecast by Type (2021-2026) 4.2.3 Hospital Acquired Pneumonia Drugs Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Hospital Acquired Pneumonia Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Hospital Acquired Pneumonia Drugs Market Size by Application (2015-2020) 5.1.1 Global Hospital Acquired Pneumonia Drugs Sales by Application (2015-2020) 5.1.2 Global Hospital Acquired Pneumonia Drugs Revenue by Application (2015-2020) 5.1.3 Hospital Acquired Pneumonia Drugs Price by Application (2015-2020) 5.2 Hospital Acquired Pneumonia Drugs Market Size Forecast by Application (2021-2026) 5.2.1 Global Hospital Acquired Pneumonia Drugs Sales Forecast by Application (2021-2026) 5.2.2 Global Hospital Acquired Pneumonia Drugs Revenue Forecast by Application (2021-2026) 5.2.3 Global Hospital Acquired Pneumonia Drugs Price Forecast by Application (2021-2026) 6 Japan by Players, Type and Application 6.1 Japan Hospital Acquired Pneumonia Drugs Market Size YoY Growth 2015-2026 6.1.1 Japan Hospital Acquired Pneumonia Drugs Sales YoY Growth 2015-2026 6.1.2 Japan Hospital Acquired Pneumonia Drugs Revenue YoY Growth 2015-2026 6.1.3 Japan Hospital Acquired Pneumonia Drugs Market Share in Global Market 2015-2026 6.2 Japan Hospital Acquired Pneumonia Drugs Market Size by Players (International and Local Players) 6.2.1 Japan Top Hospital Acquired Pneumonia Drugs Players by Sales (2015-2020) 6.2.2 Japan Top Hospital Acquired Pneumonia Drugs Players by Revenue (2015-2020) 6.3 Japan Hospital Acquired Pneumonia Drugs Historic Market Review by Type (2015-2020) 6.3.1 Japan Hospital Acquired Pneumonia Drugs Sales Market Share by Type (2015-2020) 6.3.2 Japan Hospital Acquired Pneumonia Drugs Revenue Market Share by Type (2015-2020) 6.3.3 Japan Hospital Acquired Pneumonia Drugs Price by Type (2015-2020) 6.4 Japan Hospital Acquired Pneumonia Drugs Market Estimates and Forecasts by Type (2021-2026) 6.4.1 Japan Hospital Acquired Pneumonia Drugs Sales Forecast by Type (2021-2026) 6.4.2 Japan Hospital Acquired Pneumonia Drugs Revenue Forecast by Type (2021-2026) 6.4.3 Japan Hospital Acquired Pneumonia Drugs Price Forecast by Type (2021-2026) 6.5 Japan Hospital Acquired Pneumonia Drugs Historic Market Review by Application (2015-2020) 6.5.1 Japan Hospital Acquired Pneumonia Drugs Sales Market Share by Application (2015-2020) 6.5.2 Japan Hospital Acquired Pneumonia Drugs Revenue Market Share by Application (2015-2020) 6.5.3 Japan Hospital Acquired Pneumonia Drugs Price by Application (2015-2020) 6.6 Japan Hospital Acquired Pneumonia Drugs Market Estimates and Forecasts by Application (2021-2026) 6.6.1 Japan Hospital Acquired Pneumonia Drugs Sales Forecast by Application (2021-2026) 6.6.2 Japan Hospital Acquired Pneumonia Drugs Revenue Forecast by Application (2021-2026) 6.6.3 Japan Hospital Acquired Pneumonia Drugs Price Forecast by Application (2021-2026) 7 North America 7.1 North America Hospital Acquired Pneumonia Drugs Market Size YoY Growth 2015-2026 7.2 North America Hospital Acquired Pneumonia Drugs Market Facts & Figures by Country 7.2.1 North America Hospital Acquired Pneumonia Drugs Sales by Country (2015-2020) 7.2.2 North America Hospital Acquired Pneumonia Drugs Revenue by Country (2015-2020) 7.2.3 U.S. 7.2.4 Canada 8 Europe 8.1 Europe Hospital Acquired Pneumonia Drugs Market Size YoY Growth 2015-2026 8.2 Europe Hospital Acquired Pneumonia Drugs Market Facts & Figures by Country 8.2.1 Europe Hospital Acquired Pneumonia Drugs Sales by Country 8.2.2 Europe Hospital Acquired Pneumonia Drugs Revenue by Country 8.2.3 Germany 8.2.4 France 8.2.5 U.K. 8.2.6 Italy 8.2.7 Russia 9 Asia Pacific 9.1 Asia Pacific Hospital Acquired Pneumonia Drugs Market Size YoY Growth 2015-2026 9.2 Asia Pacific Hospital Acquired Pneumonia Drugs Market Facts & Figures by Country 9.2.1 Asia Pacific Hospital Acquired Pneumonia Drugs Sales by Region (2015-2020) 9.2.2 Asia Pacific Hospital Acquired Pneumonia Drugs Revenue by Region 9.2.3 China 9.2.4 Japan 9.2.5 South Korea 9.2.6 India 9.2.7 Australia 9.2.8 Taiwan 9.2.9 Indonesia 9.2.10 Thailand 9.2.11 Malaysia 9.2.12 Philippines 9.2.13 Vietnam 10 Latin America 10.1 Latin America Hospital Acquired Pneumonia Drugs Market Size YoY Growth 2015-2026 10.2 Latin America Hospital Acquired Pneumonia Drugs Market Facts & Figures by Country 10.2.1 Latin America Hospital Acquired Pneumonia Drugs Sales by Country 10.2.2 Latin America Hospital Acquired Pneumonia Drugs Revenue by Country 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Hospital Acquired Pneumonia Drugs Market Size YoY Growth 2015-2026 11.2 Middle East and Africa Hospital Acquired Pneumonia Drugs Market Facts & Figures by Country 11.2.1 Middle East and Africa Hospital Acquired Pneumonia Drugs Sales by Country 11.2.2 Middle East and Africa Hospital Acquired Pneumonia Drugs Revenue by Country 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Basilea Pharmaceutica 12.1.1 Basilea Pharmaceutica Corporation Information 12.1.2 Basilea Pharmaceutica Description and Business Overview 12.1.3 Basilea Pharmaceutica Sales, Revenue and Gross Margin (2015-2020) 12.1.4 Basilea Pharmaceutica Hospital Acquired Pneumonia Drugs Products Offered 12.1.5 Basilea Pharmaceutica Recent Development 12.2 Meiji Holdings 12.2.1 Meiji Holdings Corporation Information 12.2.2 Meiji Holdings Description and Business Overview 12.2.3 Meiji Holdings Sales, Revenue and Gross Margin (2015-2020) 12.2.4 Meiji Holdings Hospital Acquired Pneumonia Drugs Products Offered 12.2.5 Meiji Holdings Recent Development 12.3 Cubist Pharmaceutical 12.3.1 Cubist Pharmaceutical Corporation Information 12.3.2 Cubist Pharmaceutical Description and Business Overview 12.3.3 Cubist Pharmaceutical Sales, Revenue and Gross Margin (2015-2020) 12.3.4 Cubist Pharmaceutical Hospital Acquired Pneumonia Drugs Products Offered 12.3.5 Cubist Pharmaceutical Recent Development 12.4 Aridis Pharmaceutical 12.4.1 Aridis Pharmaceutical Corporation Information 12.4.2 Aridis Pharmaceutical Description and Business Overview 12.4.3 Aridis Pharmaceutical Sales, Revenue and Gross Margin (2015-2020) 12.4.4 Aridis Pharmaceutical Hospital Acquired Pneumonia Drugs Products Offered 12.4.5 Aridis Pharmaceutical Recent Development 12.5 Valneva 12.5.1 Valneva Corporation Information 12.5.2 Valneva Description and Business Overview 12.5.3 Valneva Sales, Revenue and Gross Margin (2015-2020) 12.5.4 Valneva Hospital Acquired Pneumonia Drugs Products Offered 12.5.5 Valneva Recent Development 12.6 Bayer 12.6.1 Bayer Corporation Information 12.6.2 Bayer Description and Business Overview 12.6.3 Bayer Sales, Revenue and Gross Margin (2015-2020) 12.6.4 Bayer Hospital Acquired Pneumonia Drugs Products Offered 12.6.5 Bayer Recent Development 12.7 GlaxoSmithKline 12.7.1 GlaxoSmithKline Corporation Information 12.7.2 GlaxoSmithKline Description and Business Overview 12.7.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020) 12.7.4 GlaxoSmithKline Hospital Acquired Pneumonia Drugs Products Offered 12.7.5 GlaxoSmithKline Recent Development 12.8 Merck 12.8.1 Merck Corporation Information 12.8.2 Merck Description and Business Overview 12.8.3 Merck Sales, Revenue and Gross Margin (2015-2020) 12.8.4 Merck Hospital Acquired Pneumonia Drugs Products Offered 12.8.5 Merck Recent Development 12.9 Achaogen 12.9.1 Achaogen Corporation Information 12.9.2 Achaogen Description and Business Overview 12.9.3 Achaogen Sales, Revenue and Gross Margin (2015-2020) 12.9.4 Achaogen Hospital Acquired Pneumonia Drugs Products Offered 12.9.5 Achaogen Recent Development 12.10 AstraZeneca 12.10.1 AstraZeneca Corporation Information 12.10.2 AstraZeneca Description and Business Overview 12.10.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020) 12.10.4 AstraZeneca Hospital Acquired Pneumonia Drugs Products Offered 12.10.5 AstraZeneca Recent Development 12.11 Basilea Pharmaceutica 12.11.1 Basilea Pharmaceutica Corporation Information 12.11.2 Basilea Pharmaceutica Description and Business Overview 12.11.3 Basilea Pharmaceutica Sales, Revenue and Gross Margin (2015-2020) 12.11.4 Basilea Pharmaceutica Hospital Acquired Pneumonia Drugs Products Offered 12.11.5 Basilea Pharmaceutica Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter’s Five Forces Analysis 13.5 Primary Interviews with Key Hospital Acquired Pneumonia Drugs Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Hospital Acquired Pneumonia Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Hospital Acquired Pneumonia Drugs Market Segments Table 2. Ranking of Global Top Hospital Acquired Pneumonia Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Hospital Acquired Pneumonia Drugs Market Size Growth Rate by Type 2020-2026 (Kg) & (US$ Million) Table 4. Major Manufacturers of Phase II Table 5. Major Manufacturers of Early Phase (Phase I & II) Table 6. Global Hospital Acquired Pneumonia Drugs Market Size Growth Rate by Application 2020-2026 (Kg) Table 7. Global Hospital Acquired Pneumonia Drugs Market Size by Region (Kg) & (US$ Million): 2020 VS 2026 Table 8. Global Hospital Acquired Pneumonia Drugs Sales by Regions 2015-2020 (Kg) Table 9. Global Hospital Acquired Pneumonia Drugs Sales Market Share by Regions (2015-2020) Table 10. Global Hospital Acquired Pneumonia Drugs Revenue by Regions 2015-2020 (US$ Million) Table 11. Global Hospital Acquired Pneumonia Drugs Sales Forecast by Region (2021-2026) (Kg) Table 12. Global Hospital Acquired Pneumonia Drugs Sales by Manufacturers (2015-2020) (Kg) Table 13. Global Hospital Acquired Pneumonia Drugs Sales Share by Manufacturers (2015-2020) Table 14. Global Hospital Acquired Pneumonia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 15. Global Hospital Acquired Pneumonia Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Acquired Pneumonia Drugs as of 2019) Table 16. Hospital Acquired Pneumonia Drugs Revenue by Manufacturers (2015-2020) (US$ Million) Table 17. Hospital Acquired Pneumonia Drugs Revenue Share by Manufacturers (2015-2020) Table 18. Key Manufacturers Hospital Acquired Pneumonia Drugs Price (2015-2020) (USD/Kg) Table 19. Hospital Acquired Pneumonia Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table 20. Manufacturers Hospital Acquired Pneumonia Drugs Product Type Table 21. Date of International Manufacturers Enter into Hospital Acquired Pneumonia Drugs Market Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans Table 23. Global Hospital Acquired Pneumonia Drugs Sales by Type (2015-2020) (Kg) Table 24. Global Hospital Acquired Pneumonia Drugs Sales Share by Type (2015-2020) Table 25. Global Hospital Acquired Pneumonia Drugs Revenue by Type (2015-2020) (US$ Million) Table 26. Global Hospital Acquired Pneumonia Drugs Revenue Share by Type (2015-2020) Table 27. Hospital Acquired Pneumonia Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Kg) Table 28. Global Hospital Acquired Pneumonia Drugs Sales Share by Type (2021-2026) Table 29. Global Hospital Acquired Pneumonia Drugs Sales by Application (2015-2020) (Kg) Table 30. Global Hospital Acquired Pneumonia Drugs Sales Share by Application (2015-2020) Table 31. Global Hospital Acquired Pneumonia Drugs Sales Share by Application (2021-2026) Table 32. Global Hospital Acquired Pneumonia Drugs Sales Market Share Forecast by Application (2021-2026) Table 33. Global Hospital Acquired Pneumonia Drugs Revenue by Application (2015-2020) (US$ Million) Table 34. Global Hospital Acquired Pneumonia Drugs Revenue Market Share Forecast by Application (2021-2026) Table 35. Japan Hospital Acquired Pneumonia Drugs Sales (Kg) of Key Companies (2015-2020) Table 36. Japan Hospital Acquired Pneumonia Drugs Sales Share by Company (2015-2020) Table 37. Japan Hospital Acquired Pneumonia Drugs Revenue (US$ Million) by Company (2015-2020) Table 38. Japan Hospital Acquired Pneumonia Drugs Sales (Kg) by Type (2015-2020) Table 39. Japan Hospital Acquired Pneumonia Drugs Sales Share by Type (2015-2020) Table 40. Japan Hospital Acquired Pneumonia Drugs Revenue (US$ Million) Market Share by Type (2015-2020) Table 41. Japan Hospital Acquired Pneumonia Drugs Price (Kg) by Type (2015-2020) Table 42. Japan Hospital Acquired Pneumonia Drugs Sales (Kg) by Type (2021-2026) Table 43. Japan Hospital Acquired Pneumonia Drugs Sales Share by Type (2021-2026) Table 44. Japan Hospital Acquired Pneumonia Drugs Revenue (US$ Million) Market Share by Type (2021-2026) Table 45. Japan Hospital Acquired Pneumonia Drugs Revenue Share by Type (2021-2026) Table 46. Japan Hospital Acquired Pneumonia Drugs Price (Kg) by Type (2021-2026) Table 47. Japan Hospital Acquired Pneumonia Drugs Sales (Kg) by Application (2015-2020) Table 48. Japan Hospital Acquired Pneumonia Drugs Sales Share by Application (2015-2020) Table 49. Japan Hospital Acquired Pneumonia Drugs Revenue (US$ Million) Market Share by Application (2015-2020) Table 50. Japan Hospital Acquired Pneumonia Drugs Sales (Kg) by Application (2021-2026) Table 51. Japan Hospital Acquired Pneumonia Drugs Sales Share by Application (2021-2026) Table 52. Japan Hospital Acquired Pneumonia Drugs Revenue (US$ Million) Market Share by Application (2021-2026) Table 53. Japan Hospital Acquired Pneumonia Drugs Revenue Share by Application (2021-2026) Table 54. North America Hospital Acquired Pneumonia Drugs Sales by Country (2015-2020) (Kg) Table 55. North America Hospital Acquired Pneumonia Drugs Sales Market Share by Country (2015-2020) Table 56. North America Hospital Acquired Pneumonia Drugs Revenue by Country (2015-2020) (US$ Million) Table 57. North America Hospital Acquired Pneumonia Drugs Revenue Market Share by Country (2015-2020) Table 58. Europe Hospital Acquired Pneumonia Drugs Sales by Country (2015-2020) (Kg) Table 59. Europe Hospital Acquired Pneumonia Drugs Sales Market Share by Country (2015-2020) Table 60. Europe Hospital Acquired Pneumonia Drugs Revenue by Country (2015-2020) (US$ Million) Table 61. Europe Hospital Acquired Pneumonia Drugs Revenue Market Share by Country (2015-2020) Table 62. Asia Pacific Hospital Acquired Pneumonia Drugs Sales by Region (2015-2020) (Kg) Table 63. Asia Pacific Hospital Acquired Pneumonia Drugs Sales Market Share by Region (2015-2020) Table 64. Asia Pacific Hospital Acquired Pneumonia Drugs Revenue by Region (2015-2020) (US$ Million) Table 65. Asia Pacific Hospital Acquired Pneumonia Drugs Revenue Market Share by Region (2015-2020) Table 66. Latin America Hospital Acquired Pneumonia Drugs Sales by Country (2015-2020) (Kg) Table 67. Latin America Hospital Acquired Pneumonia Drugs Sales Market Share by Country (2015-2020) Table 68. Latin Americaa Hospital Acquired Pneumonia Drugs Revenue by Country (2015-2020) (US$ Million) Table 69. Latin America Hospital Acquired Pneumonia Drugs Revenue Market Share by Country (2015-2020) Table 70. Middle East and Africa Hospital Acquired Pneumonia Drugs Sales by Country (2015-2020) (Kg) Table 71. Middle East and Africa Hospital Acquired Pneumonia Drugs Sales Market Share by Country (2015-2020) Table 72. Middle East and Africa Hospital Acquired Pneumonia Drugs Revenue by Country (2015-2020) (US$ Million) Table 73. Middle East and Africa Hospital Acquired Pneumonia Drugs Revenue Market Share by Country (2015-2020) Table 74. Basilea Pharmaceutica Corporation Information Table 75. Basilea Pharmaceutica Description and Business Overview Table 76. Basilea Pharmaceutica Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 77. Basilea Pharmaceutica Hospital Acquired Pneumonia Drugs Product Table 78. Basilea Pharmaceutica Recent Development Table 79. Meiji Holdings Corporation Information Table 80. Meiji Holdings Description and Business Overview Table 81. Meiji Holdings Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 82. Meiji Holdings Product Table 83. Meiji Holdings Recent Development Table 84. Cubist Pharmaceutical Corporation Information Table 85. Cubist Pharmaceutical Description and Business Overview Table 86. Cubist Pharmaceutical Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 87. Cubist Pharmaceutical Product Table 88. Cubist Pharmaceutical Recent Development Table 89. Aridis Pharmaceutical Corporation Information Table 90. Aridis Pharmaceutical Description and Business Overview Table 91. Aridis Pharmaceutical Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 92. Aridis Pharmaceutical Product Table 93. Aridis Pharmaceutical Recent Development Table 94. Valneva Corporation Information Table 95. Valneva Description and Business Overview Table 96. Valneva Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 97. Valneva Product Table 98. Valneva Recent Development Table 99. Bayer Corporation Information Table 100. Bayer Description and Business Overview Table 101. Bayer Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 102. Bayer Product Table 103. Bayer Recent Development Table 104. GlaxoSmithKline Corporation Information Table 105. GlaxoSmithKline Description and Business Overview Table 106. GlaxoSmithKline Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 107. GlaxoSmithKline Product Table 108. GlaxoSmithKline Recent Development Table 109. Merck Corporation Information Table 110. Merck Description and Business Overview Table 111. Merck Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 112. Merck Product Table 113. Merck Recent Development Table 114. Achaogen Corporation Information Table 115. Achaogen Description and Business Overview Table 116. Achaogen Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 117. Achaogen Product Table 118. Achaogen Recent Development Table 119. AstraZeneca Corporation Information Table 120. AstraZeneca Description and Business Overview Table 121. AstraZeneca Hospital Acquired Pneumonia Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020) Table 122. AstraZeneca Product Table 123. AstraZeneca Recent Development Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 125. Key Challenges Table 126. Market Risks Table 127. Main Points Interviewed from Key Hospital Acquired Pneumonia Drugs Players Table 128. Hospital Acquired Pneumonia Drugs Customers List Table 129. Hospital Acquired Pneumonia Drugs Distributors List Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources List of Figures Figure 1. Hospital Acquired Pneumonia Drugs Product Picture Figure 2. Global Hospital Acquired Pneumonia Drugs Sales Market Share by Type in 2020 & 2026 Figure 3. Phase II Product Picture Figure 4. Early Phase (Phase I & II) Product Picture Figure 5. Global Hospital Acquired Pneumonia Drugs Sales Market Share by Application in 2020 & 2026 Figure 6. Hospital Pharmacies Figure 7. Retail Pharmacies Figure 8. Drug Store Figure 9. E-Commerce Figure 10. Hospital Acquired Pneumonia Drugs Report Years Considered Figure 11. Global Hospital Acquired Pneumonia Drugs Market Size 2015-2026 (US$ Million) Figure 12. Global Hospital Acquired Pneumonia Drugs Sales 2015-2026 (Kg) Figure 13. Global Hospital Acquired Pneumonia Drugs Market Size Market Share by Region: 2020 Versus 2026 Figure 14. Global Hospital Acquired Pneumonia Drugs Sales Market Share by Region (2015-2020) Figure 15. Global Hospital Acquired Pneumonia Drugs Sales Market Share by Region in 2019 Figure 16. Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Region (2015-2020) Figure 17. Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Region in 2019 Figure 18. Global Hospital Acquired Pneumonia Drugs Sales Share by Manufacturer in 2019 Figure 19. The Top 10 and 5 Players Market Share by Hospital Acquired Pneumonia Drugs Revenue in 2019 Figure 20. Hospital Acquired Pneumonia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 21. Global Hospital Acquired Pneumonia Drugs Sales Market Share by Type (2015-2020) Figure 22. Global Hospital Acquired Pneumonia Drugs Sales Market Share by Type in 2019 Figure 23. Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Type (2015-2020) Figure 24. Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Type in 2019 Figure 25. Global Hospital Acquired Pneumonia Drugs Market Share by Price Range (2015-2020) Figure 26. Global Hospital Acquired Pneumonia Drugs Sales Market Share by Application (2015-2020) Figure 27. Global Hospital Acquired Pneumonia Drugs Sales Market Share by Application in 2019 Figure 28. Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Application (2015-2020) Figure 29. Global Hospital Acquired Pneumonia Drugs Revenue Market Share by Application in 2019 Figure 30. Japan Hospital Acquired Pneumonia Drugs Sales Growth Rate 2015-2026 (Kg) Figure 31. Japan Hospital Acquired Pneumonia Drugs Revenue Growth Rate 2015-2026 (US$ Million) Figure 32. Japan Hospital Acquired Pneumonia Drugs Market Share in Global Market 2015-2026 Figure 33. Japan 5 and 10 Largest Hospital Acquired Pneumonia Drugs Players Market Share by Revenue in Hospital Acquired Pneumonia Drugs in 2019 Figure 34. Japan Hospital Acquired Pneumonia Drugs Revenue Share by Type (2015-2020) Figure 35. Japan Hospital Acquired Pneumonia Drugs Revenue Growth Rate by Type in 2015 & 2019 Figure 36. Japan Hospital Acquired Pneumonia Drugs Revenue Share by Application (2015-2020) Figure 37. Japan Hospital Acquired Pneumonia Drugs Revenue Growth Rate by Application in 2015 & 2019 Figure 38. North America Hospital Acquired Pneumonia Drugs Sales Growth Rate 2015-2020 (Kg) Figure 39. North America Hospital Acquired Pneumonia Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 40. North America Hospital Acquired Pneumonia Drugs Sales Market Share by Country in 2019 Figure 41. North America Hospital Acquired Pneumonia Drugs Revenue Market Share by Country in 2019 Figure 42. U.S. Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 43. U.S. Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. Canada Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 45. Canada Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. Europe Hospital Acquired Pneumonia Drugs Sales Growth Rate 2015-2020 (Kg) Figure 47. Europe Hospital Acquired Pneumonia Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 48. Europe Hospital Acquired Pneumonia Drugs Sales Market Share by Country in 2019 Figure 49. Europe Hospital Acquired Pneumonia Drugs Revenue Market Share by Country in 2019 Figure 50. Germany Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 51. Germany Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. France Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 53. France Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. U.K. Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 55. U.K. Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Italy Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 57. Italy Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Russia Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 59. Russia Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Asia Pacific Hospital Acquired Pneumonia Drugs Sales Growth Rate 2015-2020 (Kg) Figure 61. Asia Pacific Hospital Acquired Pneumonia Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 62. Asia Pacific Hospital Acquired Pneumonia Drugs Sales Market Share by Region in 2019 Figure 63. Asia Pacific Hospital Acquired Pneumonia Drugs Revenue Market Share by Region in 2019 Figure 64. China Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 65. China Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Japan Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 67. Japan Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. South Korea Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 69. South Korea Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. India Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 71. India Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Australia Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 73. Australia Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Taiwan Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 75. Taiwan Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Indonesia Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 77. Indonesia Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Thailand Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 79. Thailand Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Malaysia Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 81. Malaysia Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 82. Philippines Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 83. Philippines Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 84. Vietnam Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 85. Vietnam Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 86. Latin America Hospital Acquired Pneumonia Drugs Sales Growth Rate 2015-2020 (Kg) Figure 87. Latin America Hospital Acquired Pneumonia Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 88. Latin America Hospital Acquired Pneumonia Drugs Sales Market Share by Country in 2019 Figure 89. Latin America Hospital Acquired Pneumonia Drugs Revenue Market Share by Country in 2019 Figure 90. Mexico Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 91. Mexico Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 92. Brazil Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 93. Brazil Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 94. Argentina Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 95. Argentina Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 96. Middle East and Africa Hospital Acquired Pneumonia Drugs Sales Growth Rate 2015-2020 (Kg) Figure 97. Middle East and Africa Hospital Acquired Pneumonia Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 98. Middle East and Africa Hospital Acquired Pneumonia Drugs Sales Market Share by Country in 2019 Figure 99. Middle East and Africa Hospital Acquired Pneumonia Drugs Revenue Market Share by Country in 2019 Figure 100. Turkey Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 101. Turkey Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 102. Saudi Arabia Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 103. Saudi Arabia Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 104. U.A.E Hospital Acquired Pneumonia Drugs Sales Growth Rate (2015-2020) (Kg) Figure 105. U.A.E Hospital Acquired Pneumonia Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 106. Porter's Five Forces Analysis Figure 107. Hospital Acquired Pneumonia Drugs Value Chain Figure 108. Channels of Distribution Figure 109. Distributors Profiles Figure 110. Bottom-up and Top-down Approaches for This Report Figure 111. Data Triangulation Figure 112. Key Executives Interviewed

Basilea Pharmaceutica Meiji Holdings Cubist Pharmaceutical Aridis Pharmaceutical Valneva Bayer GlaxoSmithKline Merck Achaogen AstraZeneca